XPRIZE
Rapid Covid Testing Has Concluded

Competitors will create “Open Science” solutions for test-enabled safe Return-to-Work/School. XPRIZE Announcement

Competition Categories

Teams can compete in one of the following four categories:

To ensure supply chain diverse solutions, entries are encouraged in a variety of underlying testing approaches/combinations: PCR, Isothermal (e.g., LAMP/RPA), CRISPR, Antigen-detection, Next Generation Sequencing, and other technologies.

Judging Criteria

  • Cost per test

Including all materials and reagents

  • Performance

Measured & validated sensitivity, specificity and lamit of detection

  • Simplicity

Defined simple “standard operating procedures” enabling widespread, distributed adoption

  • Turnaround time

Point-of-care or at least within 12 hours to enable “next morning” results

  • Biosafety

Approach to ensure virus neutralization and safe handling

  • Innovation

Going above & beyond to improve performance, efficiency, ease-of-use, consistency, automation or other innovations

  • 200 Semi-finalists go to distributed Analytical Validation
  • 20 Finalists go to Clinical Validation at top clinical labs
  • 5 Winning teams share a multi-million $ prize purse (50% on announcement; 50% on successful real-world pilot implementation). 

Timeline

  • Competition Launch: July 28, 2020
  • Registration Deadline: August 31, 2020
  • Finalist Teams Announced (up to 20 teams): September 15, 2020
  • Pilot Teams Announced (up to 5 teams and 5 alternates): October 13, 2020
  • Pilot Round: Deployment: November 2, 2020 – January 22, 2021
  • Grand Prize Winners Announced: End of January 2021
  • Scaling Impact Phase: February – December 2021
APPLY NOW